DrugPatentWatch Database Preview
Etanercept - Biologic Drug Details
Try a free trial
See Plans and Pricing
Summary for etanercept
| Tradenames: | 1 |
| Patents: | 319 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for etanercept |
Pharmacology for etanercept
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
US Patents for etanercept
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | Massachusetts Eye and Ear Infirmary (Boston, MA) | 2034-06-16 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | Coherus Biosciences, Inc. (Redwood City, CA) | 2038-10-10 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | LUPIN LIMITED (Mumbai, Maharashtra, IN) | 2032-10-26 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | ➤ Sign Up | The William M. Yarbrough foundation (Peoria, IL) | 2032-07-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for etanercept
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2018048146 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 03068747 | ➤ Sign Up |
| Australia | 2019201129 | ➤ Sign Up |
| Spain | 2637547 | ➤ Sign Up |
| South Korea | 101850716 | ➤ Sign Up |
| Japan | 2014500482 | ➤ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for etanercept
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 10/034 | Ireland | ➤ Sign Up | PRODUCT NAME: DENOSUMAB (PROLIA ); NAT REGISTRATION NO/DATE: EU/1/10/618/001 20100526; FIRST REGISTRATION NO/DATE: EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 26/05/2010 IRELAND EU/1/10/618/001 26/05/2010 IRELAND EU/1/10/618/002 26/05/2010 IRELAND EU/1/10/618/003 26/05/2010 IRELAND EU/1/10/618/004 20100526 |
| 15/2000 | Austria | ➤ Sign Up | PRODUCT NAME: ETANERCEPT |
| 2015 00021 | Denmark | ➤ Sign Up | PRODUCT NAME: IBRUTINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 20141021 |
| 075011 | Germany | ➤ Sign Up | PRODUCT NAME: ENBREL-ETANERCEPT; NAT. REGISTRATION NO/DATE: EU/1/99/126/001 20000203; FIRST REGISTRATION: CH (LI) 55365 20000201 |
| 10C/039 | Belgium | ➤ Sign Up | PRODUCT NAME: DENOSUMAB; AUTHORISATION NUMBER AND DATE: EU/1/10/618/001 20100528 |
| 15/020 | Ireland | ➤ Sign Up | PRODUCT NAME: IBRUTINIB, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/14/945 20141021 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
